Significant Shareholder Files Intent to Sell $583K in RetinalGenix Technologies Stock
summarizeResumen
Steven Bayern, representing Bayern Capital LLC, has filed a Form 144 indicating an intent to sell 182,400 shares of RetinalGenix Technologies Inc. stock. This proposed sale, valued at approximately $583,680, represents a notable disposition by a significant shareholder. While the filer is not an officer or director, such a filing can signal a desire for liquidity or a rebalancing of portfolio holdings. Investors should monitor for actual sales and any further disclosures regarding this position.
check_boxEventos clave
-
Intent to Sell Shares
Steven Bayern, representing Bayern Capital LLC, has filed a Form 144 indicating an intent to sell 182,400 shares of common stock.
-
Significant Value
The proposed sale has an approximate market value of $583,680.00.
-
Shareholder Disposition
The filer is identified as a shareholder, not an officer or director, and the shares were acquired via warrant exercise in 2018.
auto_awesomeAnalisis
Steven Bayern, representing Bayern Capital LLC, has filed a Form 144 indicating an intent to sell 182,400 shares of RetinalGenix Technologies Inc. stock. This proposed sale, valued at approximately $583,680, represents a notable disposition by a significant shareholder. While the filer is not an officer or director, such a filing can signal a desire for liquidity or a rebalancing of portfolio holdings. Investors should monitor for actual sales and any further disclosures regarding this position.
En el momento de esta presentación, RTGN cotizaba a 3,20 $ en OTC dentro del sector Industrial Applications And Services, con una capitalización de mercado de aproximadamente 59,5 M$. El rango de cotización de 52 semanas fue de 0,25 $ a 20,00 $. Este documento fue evaluado con un sentimiento de mercado negativo y una puntuación de importancia de 7 sobre 10.